Cutaneous melanoma could be treated by immunotherapy, which only has limited efficacy
on uveal melanoma (UM). UM immunotyping for predicting immunotherapeutic responses …

Objectives Uveal melanoma (UM) is the most common primary intraocular malignancy in
adults, and immune infiltration plays a crucial role in the prognosis of UM. This study aimed …

Immunotherapy is the most promising treatment for uveal melanoma patients with
metastasis. Tumor microenvironment plays an essential role in tumor progression and …

Objective Uveal melanoma (UM) is an aggressive malignancy with a poor prognosis and no
available effective treatment. Therefore, exploring a potential prognostic marker for UM …

Background Uveal melanoma (UM) is an aggressive intraocular malignant tumor. The
present study aimed to identify the key genes associated with UM metastasis and …

Purpose The current study aimed to reveal a novel immune-related signature to evaluate
immune infiltration status and the survival outcome for patients with uveal melanoma (UM) …

AIM To construct an immune-related prognostic signature (IPS) that can distinguish and
predict prognosis in uveal melanoma (UM). METHODS The transcriptomic data and …

Background Numerous studies indicated that tumor-infiltrated immune cells (TIC) in the
microenvironment are substantially linked to immunotherapy response and cancer …

Background To identify an immune-related prognostic signature and find potential
therapeutic targets for uveal melanoma. Methods The RNA-sequencing data obtained from …

Background Uveal melanoma (UM) is the most common primary intraocular malignancy in
adults. Many previous studies have demonstrated that the infiltrating of immune and stromal …